Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Nov 28;19(11):3001-3008.
doi: 10.31557/APJCP.2018.19.11.3001.

Prognostic Value of NRAS Gene for Survival of Colorectal Cancer Patients: A Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

Prognostic Value of NRAS Gene for Survival of Colorectal Cancer Patients: A Systematic Review and Meta-Analysis

Yue Hu et al. Asian Pac J Cancer Prev. .

Abstract

Introduction: NRAS gene is associated with malignant proliferation and metastasis of colorectal cancer (CRC). But its prognostic value on CRC is still unknown. The objective of this study is to perform a meta-analysis to obtain its prognostic value on survival of CRC patients. Methods: The systematic review and meta-analysis was designed, undertaken and reported using items from the PRISMA statement. Relevant articles were identified through PubMed (containing Medline), Embase, Web of Science databases and Google scholar search engines from their inception up to October 3, 2016. The articles about NRAS on prognosis of CRC patients were enrolled. The association between NRAS and CRC survival time (including overall survival [OS], progression-free survival [PFS], and disease-free survival [DFS]) was evaluated using hazard ratio (HR) with its corresponding 95% confidence interval (CI). Results: A total of fifteen articles were included. High-expression of NRAS was significantly associated with poor OS (HR: 1.36, 95% CI: 1.15–1.61), and poor PFS (HR: 1.75, 95% CI: 1.04–2.94). The combined HR of NRAS on DFS was 0.87 (95% CI: 0.37–2.03). Subgroup analysis showed that NRAS was significantly associated with poor OS for patients from Western countries (HR: 1.38, 95% CI: 1.09–1.73), but not for those from Asian countries. Conclusions: This meta-analysis demonstrate that NRAS gene could predict the poor prognosis for the CRC patients. More large-sample cohort studies are needed to further confirm this conclusion.

Keywords: NRAS gene; colorectal cancer; prognosis; meta-analysis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow Chart of the Search Strategy
Figure 2
Figure 2
Forest Plot Evaluating the Combined HRs between NRAS and OS
Figure 3
Figure 3
Forest Plot Evaluating the Combined HRs between NRAS and PFS
Figure 4
Figure 4
Forest Plot Evaluating the Combined HRs between NRAS and DFS
Figure 5
Figure 5
Begg’s Funnel and Sensitivity Analysis Plot (A, Begg’s funnel for OS; B, sensitivity analysis for OS; C, Begg’s funnel for PFS; D, sensitivity analysis for PFS; E, Begg’s funnel for DFS; F, sensitivity analysis for DFS)

Similar articles

Cited by

References

    1. Amati B, Frank SR, Donjerkovic D, et al. Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim Biophys Acta. 2001;1471:135–45. - PubMed
    1. Andre T, Blons H, Mabro M, et al. Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy:a GERCOR efficacy, tolerance, and translational molecular study. Ann Oncol. 2013;24:412–9. - PubMed
    1. Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66:683–91. - PubMed
    1. Birkeland E, Busch C, Berge EO, et al. Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma. Clin Exp Metastasis. 2013;30:867–76. - PMC - PubMed
    1. Boisvert-Adamo K, Aplin AE. Mutant B-RAF mediates resistance to anoikis via Bad and Bim. Oncogene. 2008;27:3301–12. - PubMed